Heritage Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,014
Closed -$9K 238
2020
Q4
$9K Sell
13,014
-73
-0.6% -$155 ﹤0.01% 225
2020
Q3
$29K Sell
13,087
-98
-0.7% -$280 0.01% 206
2020
Q2
$47K Buy
+13,185
New +$47.6K 0.01% 198

Other funds holding BMY.RT

Heritage Trust's BMY.RT Position: Q1 2021 in Review

Heritage Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 13,014 shares — an estimated $9K sold.

Heritage Trust first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $47K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Heritage Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Heritage Trust sold 13,014 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9K.
  • Heritage Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • Heritage Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $47K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Heritage Trust's 13F filing for Q1 2021, filed 12 May 2021.